Effective intervention is essential to combat the coming epidemic of neurodegenerative (ND)
diseases. Nanomedicine can overcome restrictions of CNS delivery imposed by the blood …

Purpose Multiple sclerosis (MS) prognosis is often uncertain. This literature review considers
patients' understanding of, and perspectives on, MS progression to better comprehend the …

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central
nervous system (CNS). Recently, ketogenic diet (KD) supplementation has attracted great …

Microglia are innate immune cells that maintain homeostasis of the central nervous system
(CNS) and affect various neurodegenerative diseases, especially multiple sclerosis (MS) …

The number of disease-modifying therapies (DMTs) approved for the treatment of multiple
sclerosis (MS) has greatly increased in recent decades, leading to higher treatment …

Background Kinesiophobia can be a barrier for physical activity in patients with multiple
sclerosis (PwMS) and it can develop as a result of fear and avoidance reactions due to …

Background Disease-modifying therapies are given to people with multiple sclerosis (MS) to
reduce disease progression and relapse frequency. Current modes of administration include …

Multiple Sclerosis-specific fatigue may show a character that increases with physical activity
and decreases with rest, or it may become pathological fatigue by acquiring a character that …

Multiple sclerosis (MS) is an immune-mediated, demyelinating disease of the CNS, affecting
2.3 million people worldwide (50, 51). Patients with a clinically isolated syndrome (CIS) or …

Importância da atuação do farmacêutico em equipe multidisciplinar junto aos portadores de
Esclerose Múltipla para a melhori Page 1 UNIVERSIDADE DE SÃO PAULO FACULDADE DE …